Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).

ABSTRACT:

Objective

To evaluate effects of remote monitoring of adjuvant chemotherapy related side effects via the Advanced Symptom Management System (ASyMS) on symptom burden, quality of life, supportive care needs, anxiety, self-efficacy, and work limitations.

Design

Multicentre, repeated measures, parallel group, evaluator masked, stratified randomised controlled trial.

Setting

Twelve cancer centres in Austria, Greece, Norway, Republic of Ireland, and UK.

Participants

829 patients with non-metastatic breast cancer, colorectal cancer, Hodgkin's disease, or non-Hodgkin's lymphoma receiving first line adjuvant chemotherapy or chemotherapy for the first time in five years.

Intervention

Patients were randomised to ASyMS (intervention; n=415) or standard care (contro

SUBMITTER: Maguire R 

PROVIDER: S-EPMC8293749 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature